Related references
Note: Only part of the references are listed.HLA Allele-Restricted Immune-Mediated Adverse Drug Reactions: Framework for Genetic Prediction
Kanoot Jaruthamsophon et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides
Montserrat Puig et al.
FRONTIERS IN IMMUNOLOGY (2021)
HLA Class-II. Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients
Qing Zhao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
HLA-B*13:01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
Patompong Satapornpong et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions
Pooja Deshpande et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson et al.
NUCLEIC ACIDS RESEARCH (2020)
The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses
Hye Jung Park et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation
James C. Waddington et al.
TOXICOLOGICAL SCIENCES (2020)
HLA DaB1*15:01-DQB1*06:02-Restricted Human CD4+T Cells Are Selectively Activated With Amoxicillin-Peptide Adducts
Arun Tailor et al.
TOXICOLOGICAL SCIENCES (2020)
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy
Hong Liu et al.
JAMA DERMATOLOGY (2019)
Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01
Qing Zhao et al.
ALLERGY (2019)
The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions
Wei-Ti Chen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study
Paola Nicoletti et al.
GASTROENTEROLOGY (2017)
Dapsone and Nitroso Dapsone Activation of Naive T-Cells from Healthy Donors
Abdulaziz Alzahrani et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
Promiscuous T-cell responses to drugs and drug-haptens
Fiazia S. Yaseen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
HLA Restriction of Carbamazepine-Specific T-Cell Clones from an HLA-A*31:01-Positive Hypersensitive Patient
Maike Lichtenfels et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Human Leukocyte Antigen (HLA)-B☆57:01-Restricted Activation of Drug-Specific T Cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury
Manal M. Monshi et al.
HEPATOLOGY (2013)
HLA Haplotype Determines Hapten or p-i T Cell Reactivity to Flucloxacillin
Natascha Wuillemin et al.
JOURNAL OF IMMUNOLOGY (2013)
Association between HLA-B*1301 and Dapsone-Induced Hypersensitivity Reactions among Leprosy Patients in China
Hongsheng Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome
Fu-Ren Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
Michael A. Norcross et al.
AIDS (2012)
Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
Chun-Yu Wei et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Patricia T. Illing et al.
NATURE (2012)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
Tai-Ming Ko et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Generation and characterization of antigen-specific CD4(+), CD8(+), and CD4(+)CD8(+) T-cell clones from patients with carbamazopine hypersensitivity
Ying Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases
Piyush M. Vyas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Activation of T cells by carbamazepine and carbamazepine metabolites
Ying Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes
S Roychowdhury et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
DJ Naisbitt et al.
MOLECULAR PHARMACOLOGY (2003)
Haptenation of sulfonamide reactive metabolites to cellular proteins
T Manchanda et al.
MOLECULAR PHARMACOLOGY (2002)
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
S Hetherington et al.
LANCET (2002)
Hapten addition to an MHC class I-binding peptide causes substantial adjustments of the TCR structure of the responding CD8+ T cells
S Honda et al.
JOURNAL OF IMMUNOLOGY (2001)
A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug Reactions
TP Reilly et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
